Tom Barber

Tom Barber is a Chief Scientific Officer with a wealth of experience in precision medicine, genetics, and business development. Currently serving as an Independent Consultant and Chief Scientific Officer at Sequence Bio, Tom previously held leadership roles at Congenica, LifeOmic, and Eli Lilly, where they drove significant revenue growth and launched innovative healthcare products. With a PhD in Genetics from Michigan State University, Tom has made substantial contributions to cancer genetics and next-generation sequencing throughout their career. Their strategic vision and leadership have consistently guided teams through complex challenges in the biotech and pharma industries.